References in periodicals archive ?
7 million of ARS to UBS at 100% par value beginning June 30, 2010 through July 2, 2012, providing the Company a "no net cost" loan for up to 75% of market value, replacing the Company's existing $165 million UBS margin loan, reimbursing the Company approximately $800,000 for the difference between the cost-to-date of the Company's existing UBS margin loan and the applicable interest received on the Company's ARS portfolio, the Company releasing UBS from all claims except claims for consequential damages relating to the Company's sales of ARS, and the Company giving UBS the right to sell the Company's ARS without notice and UBS paying the proceeds of the sales to the Company within one day of the settlement of transaction.